CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,844 | -43.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $12,000 | +2.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $11,700 | +48.1% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $7,900 | -34.2% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $12,000 | +33.3% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | +20.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -25.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |